Since the overexpression of NF-κB and STAT3 are also correlated with hepatic inflammation [50], it is possible CP extract be developed for treating inflammation-related diseases (i.e., hepatitis and cirrhosis), as the CP potency was observed in our result accompanied by a reduction in the liver inflammation enzymes ALT/AST. The gene discussed is CP; the disease is Cirrhosis.